Urgent Voluntary Nationwide Recall of Icy Hot Heat Therapy Products For Causing First, Second and Third Degree Burns By SEO Admin on February 20, 2008

Chattem, Inc. announced February 8, 2008, that it is initiating a voluntary nationwide recall of its Icy Hot Heat Therapy products, including consumer "samples" that were included on a limited promotional basis in cartons of its 3 oz. Aspercreme product. Chattem is recalling these products because it has received some consumer reports of first, second and third degree burns as well as skin irritation resulting from consumer use or possible misuse of these products. Consumers who have the Icy Hot Heat Therapy products under recall should immediately stop using the products, discard them, and/or return them to Chattem. All lots and all sizes of the following Icy Hot Heat Therapy products are affected by this recall: 1. Icy Hot Heat Therapy Air Activated Heat- Back 2.Icy Hot Heat Therapy Air Activated Heat- Arm, Neck, and Leg 3. Icy Hot Heat Therapy Air Activated Heat- Arm, Neck, and Leg single consumer use"sample" included on a limited promotional basis in cartons of 3 oz. Aspercreme Pain Relieving Crme. Chattem notes that if products have been removed from their holding cartons the recalled products are packaged in a red colored plastic pouch which states Icy Hot Heat Therapy and either Back or Arm/Neck and Leg. Single consumer use "samples" of Icy Hot Heat Therapy- Arm, Neck and Leg were included on a limited promotional basis in yellow and red cartons of 3 oz. Aspercreme Pain Relieving Crme. The samples were distinct and stand-alone products, clearly labeled as "Icy Hot Heat Therapy Air Activated Heat," with their own internal labeling. For refund information, or to get answers to questions about the recall, call Chattem's Consumer Affairs Department at (888) 458-3487 or (888) 442-4464 Monday through Friday from 8 A.M. to 4 P.M. or visit Chattem's web site. To report any adverse reactions to Icy Hot Heat Therapy products, visit the FDA's Adverse Event Reporting Program web site or fax the FDA at (800) FDA-0178.